|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2011-5-10
|
|
pubmed:abstractText |
This study evaluates the added benefit when estimating antiretroviral drug resistance of combining all available resistance test results in a cumulative genotype relative to using the latest genotype alone.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
2040-2058
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
16
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
373-82
|
|
pubmed:meshHeading |
pubmed-meshheading:21555820-Adult,
pubmed-meshheading:21555820-Anti-HIV Agents,
pubmed-meshheading:21555820-Antiretroviral Therapy, Highly Active,
pubmed-meshheading:21555820-Drug Resistance, Viral,
pubmed-meshheading:21555820-Female,
pubmed-meshheading:21555820-Genotype,
pubmed-meshheading:21555820-HIV Infections,
pubmed-meshheading:21555820-HIV-1,
pubmed-meshheading:21555820-Humans,
pubmed-meshheading:21555820-Male,
pubmed-meshheading:21555820-Microbial Sensitivity Tests,
pubmed-meshheading:21555820-Middle Aged,
pubmed-meshheading:21555820-Mutation,
pubmed-meshheading:21555820-Predictive Value of Tests,
pubmed-meshheading:21555820-Prevalence,
pubmed-meshheading:21555820-Reverse Transcriptase Inhibitors,
pubmed-meshheading:21555820-Treatment Outcome,
pubmed-meshheading:21555820-Viral Load
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Predicting antiretroviral drug resistance from the latest or the cumulative genotype.
|
|
pubmed:affiliation |
Hospital Universitario San Cecilio, Granada, Spain.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
